Featured products include the EXCM mini H-gantry from Festo, the Firefly Dx ebola detection system, and the i.Series ultra-low freezer line from Helmer Scientific.
JAMA study data suggest that the American Thyroid Association's recommendation for indication of repeat cytology should be revised.
Selah Genomics, Greenville Health System, DecisionQ Corp, and BD have agreed to work together to “democratize genetic medicine.”
A Miami Breast Cancer Conference study and workshop have reinforced the clinical utility of bioTheranostics’ Breast Cancer Index for informing decisions about long-term endocrine therapy and assessing risk of late recurrence.
With the new contract, more than four million members across over 200 payor clients gain access to Combimatrix’s diagnostic solutions and clinical support.
Akers’ SeraStat technology enables rapid blood cell separation for small volumes of whole blood, accelerating the rate at which a test result is obtained.
The Myeloma Prognostic Risk Signature will be used as en entry criterion for a Phase II trial of an investigational new drug to treat multiple myeloma patients.
Seegene of Seoul, Republic of Korea, has received 510(k) clearance for its TOCE-based assay for herpes simplex virus (HSV) types 1 and 2, the company’s first product to clear FDA.
An innovative software application prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in identifying the roles of genes and their variants in biological processes, health, and disease.
In a head-to-head clinical study, Qiagen’s QFT test confirms lower prevalence of TB infection in China, and supports screening and preventive treatment for vulnerable populations.
FDA’s decision covers use of MammaPrint in FFPE for Agendia’s 70-gene breast cancer recurrence assay.
An agreement between Quotient and OCD assigns MosaiQ commercialization rights in the global patient testing market and donor testing markets in the developing world and Japan, while accelerating launch of the MosaiQ system.
A large-scale study shows the potential for a noninvasive urine-based test to be made available to millions of unscreened women worldwide for the detection of high-risk HPV and precancerous cervical lesions.
Financing from the French public investment bank Bpifrance will fund Magnisense’s MI² project to develop emergency cardiovascular diagnostics using magnetic nanomaterials.
MedMira’s multiplex rapid tests for HIV, syphilis, and hepatitis B and C, will be used in mobile clinics in Central Asia.
Roche will utilize Qualcomm Life’s 2net platform to capture data from a patient’s medical devices, beginning with anticoagulation meters, and transmit it to Roche’s cloud-based back-end services.
Newly issued guidance from the American Society for Colposcopy and Cervical Pathology and the Society for Gynecologic Oncology supports the use of human papilloma virus primary screening for cervical cancer.
For Immunovent’s innovative approach to allergy diagnosis, MABA names the company the “best of the best” in its year-end first pitch life science competition.
A new strategic alliance between Lockheed Martin and Illumina will use nation-scale sequencing and information systems to improve public health and wellness.
The National Science Foundation’s Small Business Innovation Research program has awarded Aperiomics a second small business grant, bringing the total NSF funds received by the company to $180,000.